What has research over the past two decades revealed about the adverse health effects of recreational cannabis use?

Addiction

Volumn 110, Issue 1, 2015, Pages 19-35

  Hall, Wayne ^a,b,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cannabis; Dependence; Drug related harms; Epidemiology; Health risks; Mental health

Indexed keywords

STREET DRUG;

ABNORMALITIES, DRUG-INDUCED; ADVERSE EFFECTS; BRAIN DISEASES; CANNABIS SMOKING; CAR DRIVING; CARDIOVASCULAR DISEASES; CHEMICALLY INDUCED; COGNITION DISORDERS; DRUG EFFECTS; EDUCATIONAL STATUS; FEMALE; FETUS DEVELOPMENT; HUMAN; MARIJUANA ABUSE; NEOPLASMS; PREGNANCY; PRENATAL EXPOSURE; PSYCHOSES, SUBSTANCE-INDUCED; PSYCHOTIC DISORDERS; RESPIRATORY TRACT DISEASES; RISK FACTOR; SCHIZOPHRENIA; STATISTICS AND NUMERICAL DATA; TRAFFIC ACCIDENT;

ABNORMALITIES, DRUG-INDUCED; ACCIDENTS, TRAFFIC; AUTOMOBILE DRIVING; BRAIN DISEASES; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; EDUCATIONAL STATUS; FEMALE; FETAL DEVELOPMENT; HUMANS; MARIJUANA ABUSE; MARIJUANA SMOKING; NEOPLASMS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PSYCHOSES, SUBSTANCE-INDUCED; PSYCHOTIC DISORDERS; RESPIRATORY TRACT DISEASES; RISK FACTORS; SCHIZOPHRENIA; STREET DRUGS;

EID: 84922264063     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/add.12703     Document Type: Article

References (165)

1. United Nations Office on Drugs and Crime. World Drug Report 2014. New York: United Nations; 2014.
2. Hall W. D., Degenhardt L. Prevalence and correlates of cannabis use in developed and developing countries. Curr Opin Psychiatry 2007; 20: 393-397.
3. Iversen L. The Science of Marijuana, 2nd edn. Oxford: Oxford University Press; 2007.
4. ElSohly M. A. Quarterly Report: December 16, 2007 thru March 15, 2008. Potency Monitoring Project Report 100. University, MS: National Center for Natural Products Research, University of Mississippi 2008.
5. McLaren J., Swift W., Dillon P., Allsop S. Cannabis potency and contamination: a review of the literature. Addiction 2008; 103: 1100-1109.
6. Hall W. D., Pacula R. Cannabis Use and Dependence: Public Health and Public Policy. Cambridge: Cambridge University Press; 2010.
7. Institute of Medicine. Marijuana and Health. Washington, DC: National Academy Press; 1982.
8. Fehr K., Kalant H., editors. Cannabis and Health Hazards: Proceedings of an ARF/WHO Scientific Meeting on Adverse Health and Behavioral Consequences of Cannabis Use. Toronto: Addiction Research Foundation; 1983.
9. Hall W. D., Solowij N., Lemon J. The Health and Psychological Consequences of Cannabis Use. Canberra: Australian Government Publishing Service; 1994.
10. Gable R. S. Comparison of acute lethal toxicity of commonly abused psychoactive substances. Addiction 2004; 99: 686-696.
11. Calabria B., Degenhardt L., Hall W. D., Lynskey M. Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of cannabis use. Drug Alcohol Rev 2010; 29: 318-330.
12. Hartung B., Kauferstein S., Ritz-Timme S., Daldrup T. Sudden unexpected death under acute influence of cannabis. Forensic Sci Int 2014; 237: e11-13.
13. Substance Abuse and Mental Health Services Administration (SAMHSA). The DAWN Report: Highlights of the 2011 Drug Abuse Warning Network (DAWN) Findings on Drug-Related Emergency Department Visits. Rockville, MD: SAMHSA, Center for Behavioral Health Statistics and Quality; 2013.
14. Smiley A. Marijuana: on road and driving simulator studies. In: Kalant H., Corrigall W., Hall W. D., Smart R., editors. The Health Effects of Cannabis. Toronto: Centre for Addiction and Mental Health; 1999, pp. 171-191.
15. Gerberich S., Sidney S., Braun B., Tekawa I., Tolan K., Quesenberry C. Marijuana use and injury events resulting in hospitalization. Ann Epidemiol 2003; 13: 230-237.
16. Mura P., Kintz P., Ludes B., Gaulier J. M., Marquet P., Martin-Dupont S. etal. Comparison of the prevalence of alcohol, cannabis and other drugs between 900 injured drivers and 900 control subjects: results of a French collaborative study. Forensic Sci Int 2003; 133: 79-85.
17. Asbridge M., Hayden J. A., Cartwright J. Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. BMJ 2012; 344: 14-17.
18. Li M. C., Brady J. E., DiMaggio C. J., Lusardi A. R., Tzong K. Y., Li G. Marijuana use and motor vehicle crashes. Epidemiol Rev 2012; 34: 65-72.
19. Hartman R. L., Huestis M. A. Cannabis effects on driving skills. Clin Chem 2013; 59: 478-492.
20. Ramaekers J. G., Berghaus G., van Laar M., Drummer O. H. Dose related risk of motor vehicle crashes after cannabis use. Drug Alcohol Depend 2004; 73: 109-119.
21. Bloch E. Effects of marijuana and cannabinoids on reproduction, endocrine function, development, and chromosomes. In: Fehr K., Kalant H., editors. Cannabis and Health Hazards. Toronto: Addiction Research Foundation; 1983, pp. 355-432.
22. Forrester M. B., Merz R. D. Risk of selected birth defects with prenatal illicit drug use, Hawaii, 1986-2002. J Toxicol Environ Health A 2007; 70: 7-18.
23. Eyler F. D., Behnke M. Early development of infants exposed to drugs prenatally. Clin Perinatol 1999; 26: 107-150.
24. Tennes K., Aritable N., Blackard C., Boyles C., Hasoun B., Holmes L. etal. Marihuana: prenatal and postnatal exposure in the human. In: Pinkert T., editor. Current Research on the Consequences of Maternal Drug Abuse. Rockville, MD: US Department of Health and Human Services; 1985, pp. 48-60.
25. Zuckerman B., Frank D. A., Hingson R., Amaro H., Levenson S. M., Kayne H. etal. Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med 1989; 320: 762-768.
26. English D., Hulse G., Milne E., Holman C., Bower C. Maternal cannabis use and birth weight: a meta-analysis. Addiction 1997; 92: 1553-1560.
27. Hayatbakhsh M. R., Flenady V. J., Gibbons K. S., Kingsbury A. M., Hurrion E., Mamun A. A. etal. Birth outcomes associated with cannabis use before and during pregnancy. Pediatr Res 2012; 71: 215-219.
28. Fergusson D. M., Horwood L. J., Northstone K. Maternal use of cannabis and pregnancy outcome. Br J Obstet Gynaecol 2002; 109: 21-27.
29. El Marroun H., Tiemeier H., Steegers E. A., Jaddoe V. W., Hofman A., Verhulst F. C. etal. Intrauterine cannabis exposure affects fetal growth trajectories: the Generation R Study. J Am Acad Child Adolesc Psychiatry 2009; 48: 1173-1181.
30. Fried P. A., Smith A. R. A literature review of the consequences of prenatal marihuana exposure: an emerging theme of a deficiency in aspects of executive function. Neurotoxicol Teratol 2001; 23: 1-11.
31. Day N. L., Richardson G. A., Goldschmidt L., Robles N., Taylor P. M., Stoffer D. S. etal. Effect of prenatal marijuana exposure on the cognitive development of offspring at age three. Neurotoxicol Teratol 1994; 16: 169-175.
32. Goldschmidt L., Day N. L., Richardson G. A. Effects of prenatal marijuana exposure on child behavior problems at age 10. Neurotoxicol Teratol 2000; 22: 325-336.
33. Goldschmidt L., Richardson G. A., Cornelius M. D., Day N. L. Prenatal marijuana and alcohol exposure and academic achievement at age 10. Neurotoxicol Teratol 2004; 26: 521-532.
34. Goldschmidt L., Richardson G. A., Willford J. A., Severtson S. G., Day N. L. School achievement in 14-year-old youths prenatally exposed to marijuana. Neurotoxicol Teratol 2012; 34: 161-167.
35. Huizink A. C., Mulder E. J. Maternal smoking, drinking or cannabis use during pregnancy and neurobehavioral and cognitive functioning in human offspring. Neurosci Biobehav Rev 2006; 30: 24-41.
36. Norberg M., Mackenzie J., Copeland J. Quantifying cannabis use with the timeline followback approach: a psychometric evaluation. Drug Alcohol Depend 2012; 121: 247-252.
37. Fergusson D. M., Horwood L. J., Ridder E. M. Tests of causal linkages between cannabis use and psychotic symptoms. Addiction 2005; 100: 354-366.
38. Macleod J., Oakes R., Copello A., Crome I., Egger M., Hickman M. etal. Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet 2004; 363: 1579-1588.
39. Anthony J. C. The epidemiology of cannabis dependence. In: Roffman R. A., Stephens R. S., editors. Cannabis Dependence: Its Nature, Consequences and Treatment. Cambridge: Cambridge University Press; 2006, pp. 58-105.
40. Anthony J., Warner L., Kessler R. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances and inhalants: basic findings from the National Comorbidity Survey. Exp Clin Psychopharmacol 1994; 2: 244-268.
41. Hall W. D., Teesson M., Lynskey M., Degenhardt L. The 12-month prevalence of substance use and ICD-10 substance use disorders in Australian adults: findings from the National Survey of Mental Health and Well-being. Addiction 1999; 94: 1541-1550.
42. van der Pol P., Liebregts N., de Graaf R., Korf D. J., van den Brink W., van Laar M. Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study. Drug Alcohol Depend 2013; 133: 352-359.
43. Lichtman A., Martin B. Cannabinoid tolerance and dependence. Handb Exp Pharmacol 2005; 168: 691-717.
44. Budney A., Hughes J. The cannabis withdrawal syndrome. Curr Opin Psychiatry 2006; 19: 233-238.
45. Allsop D. J., Copeland J., Norberg M. M., Fu S., Molnar A., Lewis J. etal. Quantifying the clinical significance of cannabis withdrawal. PLOS ONE 2012; 7: e44864.
46. Allsop D. J., Copeland J., Lintzeris N., Dunlop A. J., Montebello M., Sadler C. etal. Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial. JAMA Psychiatry 2014; 71: 281-291.
47. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Table TDI-105, Part VII: All Clients Entering Inpatient Treatment by Primary Drug and Age, 2009 or Most Recent Year Available: All Cannabis Inpatient Clients by Country and Age. Statistical Bulletin 2011: Demand for Treatment (TDI). Lisbon: EMCDDA; 2011.
48. World Health Organization (WHO). ATLAS on Substance Use (2010): Resources for the Preventions and Treatment of Substance Use Disorders. Geneva: WHO; 2010.
49. Roxburgh A., Hall W. D., Degenhardt L., McLaren J., Black E., Copeland J. etal. The epidemiology of cannabis use and cannabis-related harm in Australia 1993-2007. Addiction 2010; 105: 1071-1079.
50. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Drug Treatment Overview for Netherlands. Lisbon: EMCDDA; 2013. Available at: http://www.emcdda.europa.eu/data/treatment-overviews/Netherlands (accessed 23 July 2014). (Archived at http://www.webcitation.org/6S4yjPY59 on 25 August 2014).
51. Degenhardt L., Hall W. D. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012; 379: 55-70.
52. Florez-Salamanca L., Secades-Villa R., Budney A. J., Garcia-Rodriguez O., Wang S., Blanco C. Probability and predictors of cannabis use disorders relapse: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend 2013; 132: 127-133.
53. Roffman R., Stephens R., editors. Cannabis Dependence: Its Nature, Consequences and Treatment. Cambridge: Cambridge University Press; 2006.
54. Danovitch I., Gorelick D. A. State of the art treatments for cannabis dependence. Psychiatr Clin North Am 2012; 35: 309-326.
55. Solowij N. Marijuana and cognitive function. In: Onaivi E. S., editor. Biology of Marijuana: From Gene to Behaviour. London: Taylor & Francis; 2002, pp. 308-332.
56. Block R., O'Leary D., Hichwa R., Augustinack J., Ponto L., Ghoneim M. etal. Effects of frequent marijuana use on memory-related regional cerebral blood flow. Pharmacol Biochem Behav 2002; 72: 237-250.
57. Crane N. A., Schuster R. M., Fusar-Poli P., Gonzalez R. Effects of cannabis on neurocognitive functioning: recent advances, neurodevelopmental influences, and sex differences. Neuropsychol Rev 2013; 23: 117-137.
58. Solowij N., Battisti R. The chronic effects of cannabis on memory in humans: a review. Curr Drug Abuse Rev 2008; 1: 81-98.
59. Solowij N., Stephens R., Roffman R., Babor T., Kadden R., Miller M. etal. Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA 2002; 287: 1123-1131.
60. Solowij N., Pesa N. Cannabis and cognition: short and long term effects. In: Castle D., Murray R. M., D'Souza D. C., editors. Marijuana and Madness, 2nd edn. New York: Cambridge University Press; 2012, pp. 91-102.
61. Bolla K., Brown K., Eldreth D., Tate K., Cadet J. Dose-related neurocognitive effects of marijuana use. Neurology 2002; 59: 1337-1343.
62. Pope H., Gruber A., Hudson J., Huestis M., Yurgelun-Todd D. Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry 2001; 58: 909-915.
63. Meier M., Caspi A., Ambler A., Harrington H., Houts R., Keefe R. etal. Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci USA 2012; 109: E2657-2664.
64. Campbell A. M., Evans M., Thomson J. L., Williams M. J. Cerebral atrophy in young cannabis smokers. Lancet 1971; 2: 1219-1224.
65. Hirvonen J., Goodwin R. S., Li C. T., Terry G. E., Zoghbi S. S., Morse C. etal. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol Psychiatry 2012; 17: 642-649.
66. Quickfall J., Crockford D. Brain neuroimaging in cannabis use: a review. J Neuropsychiatry Clin Neurosci 2006; 18: 318-332.
67. Yücel M., Solowij N., Respondek C., Whittle S., Fornito A., Pantelis C. etal. Regional brain abnormalities associated with long-term heavy cannabis use. Arch Gen Psychiatry 2008; 65: 694-701.
68. Baker S. T., Yucel M., Fornito A., Allen N. B., Lubman D. I. A systematic review of diffusion weighted MRI studies of white matter microstructure in adolescent substance users. Neurosci Biobehav Rev 2013; 37: 1713-1723.
69. Batalla A., Bhattacharyya S., Yucel M., Fusar-Poli P., Crippa J. A., Nogue S. etal. Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. PLOS ONE 2013; 8: e55821.
70. Lynskey M., Hall W. D. The effects of adolescent cannabis use on educational attainment: a review. Addiction 2000; 96: 433-443.
71. Ellickson P., Bui K., Bell R., McGuigan K. Does early drug use increase the risk of dropping out of high school? J Drug Issues 1998; 28: 357-380.
72. Horwood L., Fergusson D., Hayatbakhsh M., Najman J., Coffey C., Patton G. etal. Cannabis use and educational achievement: findings from three Australasian cohort studies. Drug Alcohol Depend 2010; 110: 247-253.
73. Verweij K. J., Huizink A. C., Agrawal A., Martin N. G., Lynskey M. T. Is the relationship between early-onset cannabis use and educational attainment causal or due to common liability? Drug Alcohol Depend 2013; 133: 580-586.
74. Grant J. D., Scherrer J. F., Lynskey M. T., Agrawal A., Duncan A. E., Haber J. R. etal. Associations of alcohol, nicotine, cannabis, and drug use/dependence with educational attainment: evidence from cotwin-control analyses. Alcohol Clin Exp Res 2012; 36: 1412-1420.
75. Bergen S. E., Gardner C. O., Aggen S. H., Kendler K. S. Socioeconomic status and social support following illicit drug use: causal pathways or common liability? Twin Res Hum Genet 2008; 11: 266-274.
76. Kandel D. Stages and Pathways of Drug Involvement: Examining the Gateway Hypothesis. New York: Cambridge University Press; 2002.
77. Swift W., Coffey C., Degenhardt L., Carlin J. B., Romaniuk H., Patton G. C. Cannabis and progression to other substance use in young adults: findings from a 13-year prospective population-based study. J Epidemiol Community Health 2012; 66: e26.
78. Degenhardt L., Dierker L., Chiu W. T., Medina-Mora M. E., Neumark Y., Sampson N. etal. Evaluating the drug use 'gateway' theory using cross-national data: consistency and associations of the order of initiation of drug use among participants in the WHO World Mental Health Surveys. Drug Alcohol Depend 2010; 108: 84-97.
79. Wagner F., Anthony J. Into the world of illegal drug use: exposure opportunity and other mechanisms linking the use of alcohol, tobacco, marijuana, and cocaine. Am J Epidemiol 2002; 155: 918-925.
80. Fergusson D., Boden J., Horwood L. The developmental antecedents of illicit drug use: evidence from a 25-year longitudinal study. Drug Alcohol Depend 2008; 96: 165-177.
81. Morral A., McCaffrey D., Paddock S. Reassessing the marijuana gateway effect. Addiction 2002; 97: 1493-1504.
82. Lessem J., Hopfer C., Haberstick B., Timberlake D., Ehringer M., Smolen A. etal. Relationship between adolescent marijuana use and young adult illicit drug use. Behav Genet 2006; 36: 498-506.
83. Fergusson D., Boden J., Horwood L. Cannabis use and other illicit drug use: testing the cannabis gateway hypothesis. Addiction 2006; 101: 556-569.
84. Hall W. D., Lynskey M. Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs. Drug Alcohol Rev 2005; 24: 39-48.
85. Lynskey M., Heath A., Bucholz K., Slutske W. Escalation of drug use in early-onset cannabis users vs co-twin controls. JAMA 2003; 289: 427-433.
86. Lynskey M. T., Vink J. M., Boomsma D. I. Early onset cannabis use and progression to other drug use in a sample of Dutch twins. Behav Genet 2006; 36: 195-200.
87. Patton G. C., Coffey C., Carlin J. B., Sawyer S. M., Lynskey M. T. Reverse gateways? Frequent cannabis use as a predictor of tobacco initiation and nicotine dependence. Addiction 2005; 100: 1518-1525.
88. Agrawal A., Lynskey M. T. Tobacco and cannabis co-occurrence: does route of administration matter? Drug Alcohol Depend 2009; 99: 240-247.
89. Timberlake D. S., Haberstick B. C., Hopfer C. J., Bricker J., Sakai J. T., Lessem J. M. etal. Progression from marijuana use to daily smoking and nicotine dependence in a national sample of U.S. adolescents. Drug Alcohol Depend 2007; 88: 272-281.
90. Advisory Council on the Misuse of Drugs. Cannabis: Classification and Public Health. London: Home Office; 2008.
91. Andréasson S., Engstrom A., Allebeck P., Rydberg U. Cannabis and schizophrenia: a longitudinal study of Swedish conscripts. Lancet 1987; 2: 1483-1486.
92. Zammit S., Allebeck P., Andréasson S., Lundberg I., Lewis G. Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study. BMJ 2002; 325: 1199-1201.
93. van Os J., Bak M., Hanssen M., Bijl R. V., de Graaf R., Verdoux H. Cannabis use and psychosis: a longitudinal population-based study. Am J Epidemiol 2002; 156: 319-327.
94. Henquet C., Krabbendam L., Spauwen J., Kaplan C., Lieb R., Wittchen H. etal. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 2004; 330: 11.
95. Arseneault L., Cannon M., Poulton R., Murray R., Caspi A., Moffitt T. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ 2002; 325: 1212-1213.
96. Fergusson D., Horwood L., Swain-Campbell N. Cannabis dependence and psychotic symptoms in young people. Psychol Med 2003; 33: 15-21.
97. Moore T., Zammit S., Lingford-Hughes A., Barnes T., Jones P., Burke M. etal. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370: 319-328.
98. Degenhardt L., Hall W. D., Lynskey M. Testing hypotheses about the relationship between cannabis use and psychosis. Drug Alcohol Depend 2003; 71: 37-48.
99. Hickman M., Vickerman P., Macleod J., Kirkbride J., Jones P. Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales. Addiction 2007; 102: 597-606.
100. Boydell J., van Os J., Caspi A., Kennedy N., Giouroukou E., Fearon P. etal. Trends in cannabis use prior to first presentation with schizophrenia, in South-East London between 1965 and 1999. Psychol Med 2006; 36: 1441-1446.
101. Ajdacic-Gross V., Lauber C., Warnke I., Haker H., Murray R., Rossler W. Changing incidence of psychotic disorders among the young in Zurich. Schizophr Res 2007; 95: 9-18.
102. Saha S., Chant D., Welham J., McGrath J. A systematic review of the prevalence of schizophrenia. PLOS Med 2005; 2: e141.
103. Gottesman I. I. Schizophrenia Genesis: The Origins of Madness. New York: W.H. Freeman; 1991.
104. Large M., Sharma S., Compton M. T., Slade T., Nielssen O. Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Arch Gen Psychiatry 2011; 68: 555-561.
105. Mullin K., Gupta P., Compton M. T., Nielssen O., Harris A., Large M. Does giving up substance use work for patients with psychosis? A systematic meta-analysis. Aust NZ J Psychiatry 2012; 46: 826-839.
106. Kuepper R., van Os J., Lieb R., Wittchen H. U., Hofler M., Henquet C. Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study. BMJ 2011; 342: d738.
107. Degenhardt L., Hall W. D., Lynskey M., Coffey C., Patton G. The association between cannabis use and depression: a review of the evidence. In: Castle D., Murray R., D'Souza D., editors. Marijuana and Madness, 2nd edn. New York: Cambridge University Press; 2012, pp. 114-128.
108. Manrique-Garcia E., Zammit S., Dalman C., Hemmingsson T., Allebeck P. Cannabis use and depression: a longitudinal study of a national cohort of Swedish conscripts. BMC Psychiatry 2012; 12: 112. doi: 10.1186/471-244X-12-112.
109. Fergusson D., Horwood L. Early-onset cannabis use and psychosocial adjustment in young adults. Addiction 1997; 92: 279-296.
110. Horwood L., Fergusson D., Coffey C., Patton G., Tait R., Smart D. etal. Cannabis and depression: an integrative data analysis of four Australasian cohorts. Drug Alcohol Depend 2012; 126: 369-378.
111. Lai H., Sitharthan T. Exploration of the comorbidity of cannabis use disorders and mental health disorders among inpatients presenting to all hospitals in New South Wales, Australia. Am J Drug Alcohol Abuse 2012; 38: 567-574.
112. Lev-Ran S., Le F. B., McKenzie K., George T. P., Rehm J. Bipolar disorder and co-occurring cannabis use disorders: characteristics, co-morbidities and clinical correlates. Psychiatry Res 2013; 209: 459-465. doi: 10.1016/j.psychres.2012.12.014.
113. Silberberg C., Castle D., Koethe D. Cannabis, cannabinoids, and bipolar disorder. In: Castle D., Murray R., D'Souza D., editors. Marijuana and Madness, 2nd edn. New York: Cambridge University Press; 2012, pp. 129-136.
114. Agrawal A., Nurnberger J. I. Jr, Lynskey M. T. Cannabis involvement in individuals with bipolar disorder. Psychiatry Res 2011; 185: 459-461.
115. Henquet C., Krabbendam L., de Graaf R., ten Have M., van Os J. Cannabis use and expression of mania in the general population. J Affect Disord 2006; 95: 103-110.
116. Beautrais A., Joyce P., Mulder R. Cannabis abuse and serious suicide attempts. Addiction 1999; 94: 1155-1164.
117. van Ours J. C., Williams J., Fergusson D., Horwood L. J. Cannabis use and suicidal ideation. J Health Econ 2013; 32: 524-537.
118. Patton G., Harris J., Schwartz M., Bowes G. Adolescent suicidal behaviors: a population-based study of risk. Psychol Med 1997; 27: 715-724.
119. Rasic D., Weerasinghe S., Asbridge M., Langille D. Longitudinal associations of cannabis and illicit drug use with depression, suicidal ideation and suicidal attempts among Nova Scotia high school students. Drug Alcohol Depend 2013; 129: 49-53.
120. Arendt M., Munk-Jorgensen P., Sher L., Jensen S. O. Mortality following treatment for cannabis use disorders: predictors and causes. J Subst Abuse Treat 2013; 44: 400-406.
121. Tetrault J., Crothers K., Moore B., Mehra R., Concato J., Fiellin D. Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review. Arch Intern Med 2007; 167: 221-228.
122. Owen K. P., Sutter M. E., Albertson T. E. Marijuana: respiratory tract effects. Clin Rev Allergy Immunol 2013; 46: 65-81.
123. Tashkin D., Baldwin G., Sarafian T., Dubinett S., Roth M. D. Respiratory and immunologic consequences of marijuana smoking. J Clin Pharmacol 2002; 42: 71S-81.
124. Taylor D., Fergusson D., Milne B., Horwood L., Moffitt T., Sears M. etal. A longitudinal study of the effects of tobacco and cannabis exposure on lung function in young adults. Addiction 2002; 97: 1055-1061.
125. Pletcher M., Vittinghoff E., Kalhan R., Richman J., Safford M., Sidney S. etal. Association between marijuana exposure and pulmonary function over 20 years. JAMA 2012; 307: 173-181.
126. Tashkin D. Smoked marijuana as a cause of lung injury. Monaldi Arch Chest Dis 2005; 63: 93-100.
127. Aldington S., Williams M., Nowitz M., Weatherall M., Pritchard A., McNaughton A. etal. Effects of cannabis on pulmonary structure, function and symptoms. Thorax 2007; 62: 1058-1063.
128. Jones R. Cardiovascular system effects of marijuana. J Clin Pharmacol 2002; 42: 58S-63.
129. Sidney S. Cardiovascular consequences of marijuana use. J Clin Pharmacol 2002; 42: 64S-70.
130. Gottschalk L., Aronow W., Prakash R. Effect of marijuana and placebo-marijuana smoking on psychological state and on psychophysiological and cardiovascular functioning in angina patients. Biol Psychiatry 1977; 12: 255-266.
131. Mittleman M. A., Lewis R., Maclure M., Sherwood J., Muller J. Triggering myocardial infarction by marijuana. Circulation 2001; 103: 2805-2809.
132. Mukamal K., Maclure M., Muller J., Mittleman M. An exploratory prospective study of marijuana use and mortality following acute myocardial infarction. Am Heart J 2008; 155: 465-470.
133. Jouanjus E., Leymarie F., Tubery M., Lapeyre-Mestre M. Cannabis-related hospitalizations: unexpected serious events identified through hospital databases. Br J Clin Pharmacol 2011; 71: 758-765.
134. MacPhee D. Effects of marijuana on cell nuclei: a review of the literature relating to the genotoxicity of cannabis. In: Kalant H., Corrigall W., Hall W. D., Smart R., editors. The Health Effects of Cannabis. Toronto: Centre for Addiction and Mental Health; 1999, pp. 435-458.
135. Marselos M., Karamanakos P. Mutagenicity, developmental toxicity and carcinogeneity of cannabis. Addict Biol 1999; 4: 5-12.
136. Chan P. C., Sills R. C., Braun A. G., Haseman J. K., Bucher J. R. Toxicity and carcinogenicity of delta 9-tetrahydrocannabinol in Fischer rats and B6C3F1 mice. Fundam Appl Toxicol 1996; 30: 109-117.
137. Leuchtenberger C. Effects of marihuana (cannabis) smoke on cellular biochemistry of in vitro test systems. In: Fehr K., Kalant H., editors. Cannabis and Health Hazards. Toronto: Addiction Research Foundation; 1983, pp. 177-224.
138. Moir D., Rickert W., Levasseur G., Larose Y., Maertens R., White P. etal. A comparison of mainstream and sidestream marijuana and tobacco cigarette smoke produced under two machine smoking conditions. Chem Res Toxicol 2008; 21: 494-502.
139. Tashkin D. Effects of cannabis on the respiratory system. In: Kalant H., Corrigall W., Hall W. D., Smart R., editors. The Health Effects of Cannabis. Toronto: Centre for Addiction and Mental Health; 1999, pp. 311-345.
140. Sidney S., Quesenberry C., Friedman G., Tekawa I. Marijuana use and cancer incidence (California, United States). Cancer Causes Control 1997; 8: 722-728.
141. Zhang Z., Morgenstern H., Spitz M., Tashkin D., Yu G., Marshall J. etal. Marijuana use and increased risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev 1999; 8: 1071-1078.
142. Hashibe M., Straif K., Tashkin D., Morgenstern H., Greenland S., Zhang Z. Epidemiologic review of marijuana use and cancer risk. Alcohol 2005; 35: 265-275.
143. Mehra R., Moore B., Crothers K., Tetrault J., Fiellin D. The association between marijuana smoking and lung cancer: a systematic review. Arch Intern Med 2006; 166: 1359-1367.
144. Berthiller J., Straif K., Boniol M., Voirin N., Benhaim-Luzon V., Ayoub W. B. etal. Cannabis smoking and risk of lung cancer in men: a pooled analysis of three studies in Maghreb. J Thorac Oncol 2008; 3: 1398-1403.
145. Aldington S., Harwood M., Cox B., Weatherall M., Beckert L., Hansell A. etal. Cannabis use and risk of lung cancer: a case-control study. Eur Respir J 2008; 31: 280-286.
146. Hashibe M., Morgenstern H., Cui Y., Tashkin D., Zhang Z., Cozen W. etal. Marijuana use and the risk of lung and upper aerodigestive tract cancers: results of a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2006; 15: 1829-1834.
147. Callaghan R. C., Allebeck P., Sidorchuk A. Marijuana use and risk of lung cancer: a 40-year cohort study. Cancer Causes Control 2013; 24: 1811-1820.
148. Robinson L., Buckley J., Daigle A., Wells R., Benjamin D., Arthur D. etal. Maternal drug use and the risk of childhood nonlymphoblastic leukemia among offspring: an epidemiologic investigation implicating marijuana. Cancer 1989; 63: 1904-1911.
149. Grufferman S., Schwartz A. G., Ruymann F. B., Maurer H. M. Parents' use of cocaine and marijuana and increased risk of rhabdomyosarcoma in their children. Cancer Causes Control 1993; 4: 217-224.
150. Kuijten R. R., Bunin G. R., Nass C. C., Meadows A. T. Parental occupation and childhood astrocytoma-results of a case control study. Cancer Res 1992; 52: 782-786.
151. Reis L., Eisner M., Kosary C., Hankey B., Miller B., Clegg L. etal., editors. SEER Cancer Statistics Review, 1973-1997. Bethesda, MD: National Cancer Institute; 2000.
152. Smith M. A., Gloekler-Reiss L. A., Reis L., Gurney J., Ross J. Leukemia. In: Reis L., Eisner M., Kosary C., Hankey B., Miller B., Clegg L. etal., editors. SEER Cancer Statistics Review, 1973-1997. Bethesda, MD: National Cancer Institute; 2000, pp. 17-34.
153. Gurney J., Young J., Roffers S., Smith M. A., Bunin C. Soft tissue sarcomas. In: Reis L., Eisner M., Kosary C., Hankey B., Miller B., Clegg L. etal., editors. SEER Cancer Statistics Review, 1973-1997. Bethesda, MD: National Cancer Institute; 2000, pp. 11-123.
154. Daling J. R., Doody D. R., Sun X., Trabert B. L., Weiss N. S., Chen C. etal. Association of marijuana use and the incidence of testicular germ cell tumors. Cancer 2009; 115: 1215-1223.
155. Lacson J. C., Carroll J. D., Tuazon E., Castelao E. J., Bernstein L., Cortessis V. K. Population-based case-control study of recreational drug use and testis cancer risk confirms an association between marijuana use and nonseminoma risk. Cancer 2012; 118: 5374-5383.
156. Trabert B., Sigurdson A. J., Sweeney A. M., Strom S. S., McGlynn K. A. Marijuana use and testicular germ cell tumors. Cancer 2011; 117: 848-853.
157. Hall W. D., Swift W. The THC content of cannabis in Australia: evidence and implications. Aust NZ J Public Health 2000; 24: 503-508.
158. Slade D., Mehmedic Z., Chandra S., ElSohly M. Is cannabis becoming more potent? In: Castle D., Murray R., D'Souza D., editors. Marijuana and Madness, 2nd edn. New York: Cambridge University Press; 2012, pp. 35-52.
159. Mehmedic Z., Chandra S., Slade D., Denham H., Foster S., Patel A. S. etal. Potency trends of Delta9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008. J Forensic Sci 2010; 55: 1209-1217.
160. Atakan Z. Cannabis, a complex plant: different compounds and different effects on individuals. Ther Adv Psychopharmacol 2012; 2: 241-254.
161. van der Pol P., Liebregts N., Brunt T., van Amsterdam J., de Graaf R., Korf D. J. etal. Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study. Addiction 2014; 109: 1101-1109.
162. Fergusson D. M., Horword L. J., Swain-Campbell N. Cannabis use and psychosocial adjustment in adolescence and young adulthood. Addiction 2002; 97: 1123-1135.
163. Patton G. C., Coffey C., Carlin J. B., Degenhardt L., Lynskey M. T., Hall W. D. Cannabis use and mental health in young people: cohort study. BMJ 2002; 325: 1195-1198.
164. Swift W., Coffey C., Carlin J. B., Degenhardt L., Patton G. C. Adolescent cannabis users at 24 years: trajectories to regular weekly use and dependence in young adulthood. Addiction 2008; 103: 1361-1370.
165. Wittchen H. U., Frohlich C., Behrendt S., Gunther A., Rehm J., Zimmermann P. etal. Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal community study in adolescents. Drug Alcohol Depend 2007; 88: S60-70.